Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January - February - March - April -
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
| 2002 -
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
March 2002 - 35 products
IP
CI
A
Ritalin LA 20 mg
30 Capsule(s)
32.00
50.85
10 %
Novartis Pharma
Schweiz AG
A+ / SL / SO
FB
G
IP
CI
A
Ritalin LA 30 mg
30 Capsule(s)
41.57
61.20
10 %
Novartis Pharma
Schweiz AG
A+ / SL / SO
FB
G
IP
CI
A
Ritalin LA 20 mg
100 Capsule(s)
90.66
114.05
10 %
Novartis Pharma
Schweiz AG
A+ / SL / SO
FB
G
IP
CI
A
Ritalin LA 30 mg
100 Capsule(s)
117.77
143.25
10 %
Novartis Pharma
Schweiz AG
A+ / SL / SO
FB
G
IP
CI
Effigel
60 g
2.03
4.20
10 %
Gel: Diclofenacum Epolaminum 12.92 mg
IBSA Institut
Biochimique SA
D / SL / SO
FB
G
IP
CI
Daivobet
30 g
21.14
39.15
10 %
Ointment: 2 Active Agents
LEO Pharmaceutical
Products Sarath Ltd.
B / SL / SO
FB
G
IP
CI
Daivobet
60 g
37.19
56.45
10 %
Ointment: 2 Active Agents
LEO Pharmaceutical
Products Sarath Ltd.
B / SL / SO
FB
G
IP
CI
A
Ritalin LA 40 mg
30 Capsule(s)
48.00
68.10
10 %
Capsules: Methylphenidati Hydrochloridum 40 mg
Novartis Pharma
Schweiz AG
A+ / SL / SO
FB
G
IP
CI
A
Ritalin LA 40 mg
100 Capsule(s)
135.99
162.85
10 %
Capsules: Methylphenidati Hydrochloridum 40 mg
Novartis Pharma
Schweiz AG
A+ / SL / SO
FB
G
IP
CI
Cortinasal 50
10 ml
11.56
29.00
10 %
Nasal spray: Budesonidum 50 µg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Cortinasal 100
10 ml
21.63
39.95
10 %
Nasal spray: Budesonidum 100 µg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Atrovent N
200 inhalation(s)
9.52
26.75
10 %
Metered dose aerosol: Ipratropii Bromidum 21 µg
Boehringer Ingelheim
(Schweiz) GmbH
B / SL
FB
G
L
IP
CI
Caverject DC 10
2 syringe(s)
16.39
34.25
10 %
Injection preparation: Alprostadilum 10 µg
Pfizer AG
●
A / SL
FB
G
L
IP
CI
Caverject DC 20
2 syringe(s)
27.78
46.65
10 %
Pulver und Lösungsmittel zur Herstellung einer Injektionslösung in einer Fertigspritze: Alprostadilum 20 µg
Pfizer AG
●
A / SL
FB
G
IP
CI
Fluomizin
‐
I
6 Tablet(s)
9.24
26.45
10 %
Vaginal tablets: Dequalinii Chloridum 10 mg
Medinova AG
B / SL
FB
G
IP
CI
A
Ritalin LA 10 mg
30 Capsule(s)
PR
PR
k.A.
Novartis Pharma
Schweiz AG
A+
FB
G
IP
CI
A
Ritalin LA 10 mg
100 Capsule(s)
PR
PR
k.A.
Novartis Pharma
Schweiz AG
A+
FB
G
IP
CI
Nicotinell Mint 1 mg
36 Tablet(s)
PR
PR
k.A.
Lozenges: Nicotinum 1 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Mint 1 mg
96 Tablet(s)
PR
PR
k.A.
Lozenges: Nicotinum 1 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Mint 1 mg
204 Tablet(s)
PR
PR
k.A.
Lozenges: Nicotinum 1 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Mint 2 mg
36 Tablet(s)
PR
PR
k.A.
Lozenges: Nicotinum 2 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Mint 2 mg
96 Tablet(s)
PR
PR
k.A.
Lozenges: Nicotinum 2 mg
Haleon Schweiz AG
D / LPPV
FB
G
IP
CI
Nicotinell Mint 2 mg
204 Tablet(s)
PR
PR
k.A.
Lozenges: Nicotinum 2 mg
Haleon Schweiz AG
D
FB
G
IP
CI
Effigel
100 g
PR
PR
k.A.
Gel: Diclofenacum Epolaminum 12.92 mg
IBSA Institut
Biochimique SA
D
FB
G
CI
H
Sanukehl Pseu D6
10 ml
PR
PR
k.A.
Drops: Pseudomonas Aeruginosa Extractum (Lyophil., Steril.) Aquos D6 Dilutio
ebi-pharm ag
B
FB
G
IP
CI
Uprima 2 mg
4 Tablet(s)
PR
PR
k.A.
Sublingual tablets: 2 Active Agents
Abbott AG
B
FB
G
IP
CI
Uprima 2 mg
12 Tablet(s)
PR
PR
k.A.
Sublingual tablets: 2 Active Agents
Abbott AG
B
FB
G
IP
CI
Uprima 3 mg
4 Tablet(s)
PR
PR
k.A.
Sublingual tablets: 2 Active Agents
Abbott AG
B
FB
G
IP
CI
Uprima 3 mg
12 Tablet(s)
PR
PR
k.A.
Sublingual tablets: 2 Active Agents
Abbott AG
B
FB
G
Nicotimed
7 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 17.5 mg
NOVARTIS CONSUMER
HEALTH SCHWEIZ AG
C
FB
G
Nicotimed
21 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 17.5 mg
NOVARTIS CONSUMER
HEALTH SCHWEIZ AG
C
FB
G
Nicotimed
7 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 35 mg
NOVARTIS CONSUMER
HEALTH SCHWEIZ AG
C
FB
G
Nicotimed
21 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 35 mg
NOVARTIS CONSUMER
HEALTH SCHWEIZ AG
C
FB
G
Nicotimed
7 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 52.5 mg
NOVARTIS CONSUMER
HEALTH SCHWEIZ AG
C
FB
G
Nicotimed
21 plaster(s)
PR
PR
k.A.
Transdermal System: Nicotinum 52.5 mg
NOVARTIS CONSUMER
HEALTH SCHWEIZ AG
C
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
